Amanda Rangel, MS, CCRC

Senior Vice President, Business Development
Total Diversity Clinical Trial Management

Amanda is well established and an expert in building relationships within the clinical trials industry. Her broad skill set covers business development, marketing, patient recruitment and operational roles within various organization types, including small sites, large global site networks, CROs, technology providers and startups.

Amanda has dedicated her career to improving the quality and efficiency of clinical trial conduct. Before Total Diversity, Amanda served as executive vice president of business development for VirTrial, a leading telehealth and decentralized clinical trial (DCT) platform provider designed specifically for clinical trials. Anticipating the need to support DCTs at the site level well in advance of COVID-19, VirTrial was thoughtfully positioned to support the continuity of clinical trial conduct throughout the pandemic. In her position, Amanda became a sought after DCT subject matter expert and speaker across the globe. VirTrial was ultimately acquired by Signant Health in 2020.

Prior to VirTrial, Amanda led the US-based global sales team for Synexus, the largest site network in the world with 200 sites across 11 countries. With centralized administrative processes and standardized business functions, the unique efficiencies of Synexus set it apart from other clinical research sites and ultimately led to its acquisition by PPD in 2015.

For the last decade, Amanda has been an active contributing member for the Society of Clinical Research Sites (SCRS), whose mission is to unify the voice of the global clinical research site community for site sustainability.

Amanda earned a Bachelor’s degree in Kinesiology from Arizona State University and a Master’s degree in Integrative Physiology from the University of Colorado at Boulder.

Related Sessions

View full schedule